Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Anticancer Research|October 1, 2021
The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor MicroenvironmentPrajwal Neupane, Kosaku Mimura, Shotaro Nakajima, et al.
British Journal of Cancer|December 11, 2021
SH2D4A downregulation due to loss of chromosome 8p is associated with poor prognosis and low T cell infiltration in colorectal cancerTakuro Matsumoto, Hirokazu Okayama, Shotaro Nakajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2014
[Significant prognostic factors in stage IV gastric cancer]Okihide Suzuki, Minoru Fukuchi, Hisashi Onozawa, et al.
Anticancer Research|June 26, 2024
Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With Colorectal CancerHideaki Tsumuraya, Kosaku Mimura, Shotaro Nakajima, et al.
Plos One|February 17, 2021
Downregulation of PAICS due to loss of chromosome 4q is associated with poor survival in stage III colorectal cancerYusuke Kobayashi, Kensuke Kumamoto, Hirokazu Okayama, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 8, 2020
Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancerLeo Yamada, Motonobu Saito, Aung Kyi Thar Min, et al.
Cancer Immunology, Immunotherapy : CII|April 16, 2022
Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancerAkinao Kaneta, Shotaro Nakajima, Hirokazu Okayama, et al.
International Journal of Molecular Sciences|December 2, 2020
Tn Antigen Expression Defines an Immune Cold Subset of Mismatch-Repair Deficient Colorectal CancerTakuro Matsumoto, Hirokazu Okayama, Shotaro Nakajima, et al.
Scientific Reports|January 22, 2021
PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanismsHiroshi Nakano, Motonobu Saito, Shotaro Nakajima, et al.
Pageof 5